Cargando…

Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases

Retinal diseases are one of the leading causes of blindness globally. The mainstay treatments for these blinding diseases are laser photocoagulation, vitrectomy, and repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) or steroids. Unfortunately, these therapies are ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahaling, Binapani, Low, Shermaine W. Y., Ch, Sanjay, Addi, Utkarsh R., Ahmad, Baseer, Connor, Thomas B., Mohan, Rajiv R., Biswas, Swati, Chaurasia, Shyam S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383092/ https://www.ncbi.nlm.nih.gov/pubmed/37514191 http://dx.doi.org/10.3390/pharmaceutics15072005

Ejemplares similares

Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders
por: Mahaling, Binapani, et al.
Publicado: (2022)

Nanomedicine Approaches for Corneal Diseases
por: Chaurasia, Shyam S., et al.
Publicado: (2015)

Azithromycin Protects Retinal Glia Against Oxidative Stress-Induced Morphological Changes, Inflammation, and Cell Death
por: Mahaling, Binapani, et al.
Publicado: (2022)

Small Leucine-Rich Proteoglycans (SLRPs) in the Retina
por: Low, Shermaine W. Y., et al.
Publicado: (2021)

Immunotoxicity Considerations for Next Generation Cancer Nanomedicines
por: Hannon, Gary, et al.
Publicado: (2019)

New Insights into RPE-Photoreceptor Complex Ultrastructure using Focused Ion Beam-Scanning Election Microscopy (FIB-SEM)
por: Low, Shermaine W.Y., et al.
Publicado: (2023)

Decorin Concentrations in Aqueous Humor of Patients with Diabetic Retinopathy
por: Low, Shermaine W. Y., et al.
Publicado: (2021)

Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease
por: Li, De-feng, et al.
Publicado: (2022)

Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment
por: Chakraborty, Kasturee, et al.
Publicado: (2022)

Development of next generation nanomedicine-based approaches for the treatment of cancer: we've barely scratched the surface
por: Tracey, Shannon R., et al.
Publicado: (2021)

Mustard Gas Exposure Actuates SMAD2/3 Signaling to Promote Myofibroblast Generation in the Cornea
por: Sinha, Nishant R., et al.
Publicado: (2023)

Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics
por: Mao, Yuqiang, et al.
Publicado: (2020)

Gene editing for corneal disease management
por: Raikwar, Sudhanshu P, et al.
Publicado: (2016)

Next-generation genetic testing for retinitis pigmentosa
por: Neveling, Kornelia, et al.
Publicado: (2012)

Retinal prostheses: progress toward the next generation implants
por: Ghezzi, Diego
Publicado: (2015)

Next-Generation Sequencing Applications for Inherited Retinal Diseases
por: Dockery, Adrian, et al.
Publicado: (2021)

3D printing technology in nanomedicine
por: Ahmad, Nabeel, et al.
Publicado: (2019)

The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease
por: Martinez Velazquez, Luis A., et al.
Publicado: (2021)

Next-generation sequencing-based genetic testing and phenotype correlation in retinitis pigmentosa patients from India
por: Sen, Parveen, et al.
Publicado: (2023)

Is next-generation radiologist ready for the challenges?
por: Mohan, Chander
Publicado: (2019)

Protein-Corona-by-Design in 2D: A Reliable Platform to Decode Bio–Nano Interactions for the Next-Generation Quality-by-Design Nanomedicines
por: Mei, Kuo-Ching, et al.
Publicado: (2018)

Progress and prospects of next-generation sequencing testing for inherited retinal dystrophy
por: Chiang, John (Pei-Wen), et al.
Publicado: (2015)

Panel-Based Population Next-Generation Sequencing for Inherited Retinal Degenerations
por: Carrigan, Matthew, et al.
Publicado: (2016)

Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing
por: Weisschuh, Nicole, et al.
Publicado: (2016)

Nanomedicine
por: Howard, Kenneth A, et al.
Publicado: (2016)

Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
por: Yang, Yuqi, et al.
Publicado: (2022)

Commercial utilities and future perspective of nanomedicines
por: Malviya, Rishabha, et al.
Publicado: (2021)

Next-Generation Multimodality of Nanomedicine Therapy: Size and Structure Dependence of Folic Acid Conjugated Copolymers Actively Target Cancer Cells in Disabling Cell Division and Inducing Apoptosis
por: Sambi, Manpreet, et al.
Publicado: (2019)

HLA Typing for the Next Generation
por: Mayor, Neema P., et al.
Publicado: (2015)

Detecting genetic variations in hereditary retinal dystrophies with next-generation sequencing technology
por: Jin, Xin, et al.
Publicado: (2014)

Next generation spin torque memories
por: Kaushik, Brajesh Kumar, et al.
Publicado: (2017)

ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis
por: Lim, Rayne R., et al.
Publicado: (2016)

Editorial: Women in nanomedicine
por: Chuah, Lay-Hong, et al.
Publicado: (2023)

Applying next generation sequencing with microdroplet PCR to determine the disease-causing mutations in retinal dystrophies
por: Wang, Xinjing, et al.
Publicado: (2017)

Collagen matrix perturbations in corneal stroma of Ossabaw mini pigs with type 2 diabetes
por: Sinha, Nishant R., et al.
Publicado: (2021)

The handbook of nanomedicine
por: Jain, Kewal K
Publicado: (2017)

Principles of nanomedicine
por: Bhattacharjee, Sourav
Publicado: (2019)

The era of nanomedicine
por: Grenha, Ana
Publicado: (2011)

Bionanotechnology and Nanomedicine
por: Chase, P. Bryant, et al.
Publicado: (2012)

Handbook of nanomedicine
por: Jain, Kewal K
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0g06crvl1nscl0ii3h9lmpj6k0